ARS Pharmaceuticals, Inc.

SPRY·NasdaqGM
Compare
4.1800−0.0500 (−1.18%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours4.4600+0.2800 (+6.70%)Oct 12, 4:48 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close4.2300
Open4.2000
Day range4.06004.2700
52-week range3.985013.1500
Off day high−2.11%
Off 52-week high−68.21%
Volume1.27M
Avg. volume (3M)1.86M
Market cap415.69M
EPS (TTM)-2.18
Forward P/E-4.66
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding99.45M
Short interest—
Earnings dateAug 13, 2026 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
SPRY AVIR ARDX ACRS ARMP EPRX
Market cap 415.69M 403.43M 833.95M 529.92M 134.97M 483.66M
P/E (TTM) — — — — — —
Forward P/E -4.7 -3.4 11.1 -4.6 -1.8 -7.1
Price/book 33.2 2.0 5.4 4.0 -0.6 4.7
Dividend yield — — — — — —
1-year change −61.30% +60.19% −35.53% +88.48% +10.67% +23.31%
Today −1.18% −2.33% −1.52% −6.01% 0.00% −1.88%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All SPRY news ›
markets.businessinsider.com·

SpyGlass Pharma to Participate in Upcoming Investor Conferences

IRVINE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma” or “Company”), a late-stage biopharmaceutical company, today announced that members of the executive management team will participate…

From articles in the 4Search news index.

In the news

139mentions in 30 days
48with it in the headline
Negativesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.